Armengol, E.; Asunción, T.; Viñas, M.; Sierra, J.M.
When Combined with Colistin, an Otherwise Ineffective Rifampicin–Linezolid Combination Becomes Active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii. Microorganisms 2020, 8, 86.
https://doi.org/10.3390/microorganisms8010086
AMA Style
Armengol E, Asunción T, Viñas M, Sierra JM.
When Combined with Colistin, an Otherwise Ineffective Rifampicin–Linezolid Combination Becomes Active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii. Microorganisms. 2020; 8(1):86.
https://doi.org/10.3390/microorganisms8010086
Chicago/Turabian Style
Armengol, Eva, Teresa Asunción, Miguel Viñas, and Josep Maria Sierra.
2020. "When Combined with Colistin, an Otherwise Ineffective Rifampicin–Linezolid Combination Becomes Active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii" Microorganisms 8, no. 1: 86.
https://doi.org/10.3390/microorganisms8010086
APA Style
Armengol, E., Asunción, T., Viñas, M., & Sierra, J. M.
(2020). When Combined with Colistin, an Otherwise Ineffective Rifampicin–Linezolid Combination Becomes Active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii. Microorganisms, 8(1), 86.
https://doi.org/10.3390/microorganisms8010086